Suven Life Sciences Limited (BOM:530239)
126.30
-0.65 (-0.51%)
At close: Apr 17, 2025
Suven Life Sciences Revenue
Suven Life Sciences had revenue of 16.10M INR in the quarter ending December 31, 2024, a decrease of -34.31%. This brings the company's revenue in the last twelve months to 75.74M, down -36.75% year-over-year. In the fiscal year ending March 31, 2024, Suven Life Sciences had annual revenue of 116.93M, down -13.99%.
Revenue (ttm)
75.74M
Revenue Growth
-36.75%
P/S Ratio
405.40
Revenue / Employee
537.16K
Employees
141
Market Cap
30.70B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 116.93M | -19.02M | -13.99% |
Mar 31, 2023 | 135.95M | 16.44M | 13.76% |
Mar 31, 2022 | 119.51M | -21.23M | -15.08% |
Mar 31, 2021 | 140.73M | -6.32M | -4.30% |
Mar 31, 2020 | 147.05M | -2.71B | -94.86% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,398.38B |
HDFC Bank | 2,728.47B |
Tata Consultancy Services | 2,553.24B |
Bharti Airtel | 1,627.08B |
ICICI Bank | 2,006.54B |
State Bank of India | 3,409.52B |
Infosys | 1,647.16B |
Bajaj Finance | 358.05B |
Suven Life Sciences News
- 3 months ago - Suven Life Sciences shares surge over 8% after clinical trial update - Business Upturn
- 3 months ago - Suven Life Sciences initiates Phase-1 clinical trial for SUVN-I6107 - Business Upturn
- 7 months ago - Suven Life Sciences reports positive Phase-2a results for Ropanicant in treating Major Depressive Disorder - Business Upturn
- 8 months ago - Suven Life Sciences announces FDA acceptance of Investigational New Drug - Business Upturn